Johnston, Johnny v. Siskin Steel & Supply Co./Reliance Steel & Aluminum Co. ( 2020 )


Menu:
  •                                                                                   FILED
    May 08, 2020
    01:42 PM(CT)
    TENNESSEE
    WORKERS' COMPENSATION
    APPEALS BOARD
    TENNESSEE BUREAU OF WORKERS’ COMPENSATION
    WORKERS’ COMPENSATION APPEALS BOARD
    Johnny Johnston                              )   Docket Nos.    2015-01-0023, 2018-01-
    )                  0003, & 2018-01-0008
    v.                                           )
    )   State File Nos. 9602-2015, 266-2018, &
    Siskin Steel & Supply Co./Reliance           )                   1326-2018
    Steel & Aluminum Co., et al.                 )
    )
    )
    Appeal from the Court of Workers’            )   Heard March 24, 2020, at Knoxville
    Compensation Claims                          )
    Thomas L. Wyatt, Judge                       )
    Reversed and Certified as Final
    In this appeal, the employer challenges the trial court’s determination that the employee’s
    liver, kidney, and cardiac conditions, which the trial court concluded were an
    occupational disease, arose primarily from exposure to heavy metal contaminants in the
    workplace. The trial court concluded the testimony of the employee’s expert witnesses
    should be afforded greater weight than the testimony of the employer’s experts and that
    the employee had proven by a preponderance of the evidence that his alleged
    occupational diseases arose primarily out of and in the course and scope of his
    employment, considering all causes. The employer contends the trial court erred in
    assessing the weight given the expert testimony and asserts the preponderance of the
    evidence weighs against the trial court’s conclusions. The employee asserts the trial
    court correctly weighed the medical proof but questions the constitutionality of the
    statutory definition of “injury” and “personal injury” as applied to occupational diseases.
    Having carefully reviewed the record, we reverse the trial court’s order awarding benefits
    and certify as final the trial court’s order as reversed.
    Judge Pele I. Godkin delivered the opinion of the Appeals Board in which Presiding
    Judge Timothy W. Conner and Judge David F. Hensley joined.
    John Barringer, Nashville, Tennessee, for the employer-appellant, Siskin Steel & Supply
    Company/Reliance Steel & Aluminum Company
    Linn Guerrero-Justice, Knoxville, Tennessee, for the employee-appellee, Johnny
    Johnston
    1
    Factual and Procedural Background
    Johnny Johnston (“Employee”) was sixty-one years of age at the time of trial and
    had worked for approximately thirty-nine years at Siskin Steel & Supply
    Company/Reliance Steel & Aluminum Company (“Employer”) in Chattanooga,
    Tennessee. Employee alleged that he developed certain occupational diseases as a result
    of exposure to heavy metal contaminants while working in the course and scope of his
    employment. Employee testified to working different jobs for Employer, beginning as a
    scrapyard laborer in 1980. His job in Employer’s scrapyard involved putting different
    types of scrap metal into a machine that would sort the metals before separating them into
    different bins. Employee testified that while working in this area, some of the metal
    particles got onto his clothing and were inhaled. While in the scrapyard, Employee also
    learned to operate various machines and heavy equipment. He testified the area was
    greasy, dirty, and smelled of gas and diesel, describing “just normal, typical equipment
    stuff.” Employee wore a hard hat, steel-toed boots, safety glasses, and gloves to handle
    metal, but he was not required to wear any type of respiratory protective equipment while
    working in the scrapyard.
    After working approximately ten years in the scrapyard, Employee began working
    inside Employer’s facility fulfilling and moving orders. He testified that when certain
    machines in the plant “would get a little bit rusty[,] they’d throw diesel fuel, spray diesel
    fuel on it.” Employer testified the facility is approximately 425,000 square feet and the
    roof is “at least a hundred-plus feet” high. While in the facility, Employee also worked in
    the structural bay operating overhead cranes. He testified the area was smoky, smelled
    like gas, and would sometimes burn his eyes. In addition, he testified that trucks would
    enter and exit the bay doors throughout the day and that the building was not climate
    controlled. At trial, Employee testified that his primary job involved operating cranes
    and loading trucks for the first sixteen years of his employment.
    Employee began working as a saw operator in 1996, which involved sawing
    stainless steel, aluminum angles, and different kinds of pipe. While working in this
    capacity, Employee wore several types of personal protective equipment but did not wear
    a mask or respirator. Employee testified that he operated machines that cut metal and
    ground rock and that he also performed spot welding. He used cutting fluid on the blades
    and testified he worked about a foot away from the machines. Employee claimed the air
    would look and smell like smoke at times, and he testified he was exposed to fumes and
    dust particles. Following a heart attack in December 2016, Employee moved to another
    department to work as a saw operator. Employee also acknowledged that he occasionally
    cut steel outside of work, testifying it was usually to “cut a piece [of steel] or something
    like that at the house to make a stand[.]” He alleges his work activities over the course of
    thirty-nine years without wearing a mask or other respiratory protection resulted in
    occupational exposure to heavy metals that caused various occupational diseases.
    2
    In 2013, Employee was diagnosed with granulomatous hepatitis with non-
    alcoholic cirrhosis of the liver. A hair test conducted in 2014 was reported as revealing
    the presence of elevated levels of heavy metal contaminants, and Employee’s physician
    recommended treatment, but when Employee reported the results to Employer, his claim
    for workers’ compensation benefits was denied. As noted above, Employee suffered a
    heart attack in December 2016 and, as a result, he underwent surgery for the placement of
    stents and a pacemaker. During a 2017 evaluation with Dr. Edward Workman, a
    neuropsychiatrist, Employee was diagnosed with chronic kidney disease.
    Employee filed three separate petitions for workers’ compensation benefits,
    claiming he suffered from work-related liver disease, work-related kidney disease, and a
    work-related heart attack. 1 Because Employee alleged each condition arose from the
    same occupational exposures, the trial court consolidated the claims. 2 During the
    November 14, 2019 trial, the parties presented medical testimony by deposition.
    Employee relied on the medical opinions of Dr. Edward Workman, a neuropsychiatrist,
    and Dr. Matthew Lee, a physician, pharmacist, and toxicologist. Employer relied on the
    medical opinions of Dr. Johnathan Schneider, a gastroenterologist; Dr. Douglas Linfert, a
    nephrologist; and Dr. William Fleet, a cardiologist.
    Employee’s Expert Testimony
    Dr. Workman
    Dr. Workman is board certified in pain medicine, psychiatry, neurology, and
    forensic medicine. He performed a medical records review and first interviewed
    Employee on June 9, 2017. Dr. Workman recorded a medical history of Type II
    Diabetes, cardiovascular disease with congestive heart failure, atrial fibrillation,
    gastrointestinal reflux, airways disease with pleural thickening, chronic renal failure,
    1
    Employee filed petitions for medical and indemnity benefits for: (1) liver disease, alleging a date of
    injury of January 30, 2015, which was reported to Employer on February 9, 2015; (2) kidney disease,
    alleging a date of injury of August 29, 2017, which was reported to Employer on January 8, 2018; and (3)
    a heart attack, alleging a date of injury of December 29, 2016, which was reported to Employer on
    January 8, 2018. The parties introduced evidence addressing whether Employee’s heart disease was an
    occupational disease, and Employer has not raised any issue concerning the trial court’s expansion of
    Employee’s claim of a compensable heart attack to include a claim for an occupational heart disease.
    2
    At various times during the course of this litigation, the parties, the medical experts, and the trial court
    used the terms “condition” and “disease” interchangeably. The term “occupational disease” was defined
    in Tennessee Code Annotated section 50-6-301, but the legislature, in effect, repealed that section as of
    July 1, 2014 by not including it in the 2013 Workers’ Compensation Reform Act, thus removing any
    definition of the term “occupational disease” from the workers’ compensation statutes. We conclude the
    terms “condition” and “disease” are not synonymous, as any person may have a “condition” that does not
    arise from a disease process. Nevertheless, because the issue has not been raised by the parties, we
    generally use those terms as used by the parties, the medical experts, and the trial court.
    3
    hypertension, hypercholesterolemia, and granulomatous hepatic cirrhosis. Dr. Workman
    also documented Employee’s family history of cardiovascular disease. He saw Employee
    twice, once for the initial evaluation and once for an impairment rating evaluation.
    In determining the nature and cause of Employee’s various diseases, Dr. Workman
    relied upon a Genova Diagnostics Elemental Analysis (“Genova Screen”) to determine
    Employee’s levels of heavy metal contaminant exposure. Dr. Workman testified that
    Employee’s liver disease was due in large part to exposure to antimony, cadmium, lead,
    and gadolinium as detailed in the Genova Screen. When asked whether lead exposure
    was the primary cause of Employee’s liver cirrhosis, Dr. Workman responded, “[i]t’s one
    of several primary causes.” Dr. Workman testified that testing hair is a superior way to
    determine chronic exposure to heavy metal contaminants because it is a cumulative
    measure, whereas blood and urine tests are acute measures, noting that “[s]ome people
    like hair, some people like urine, some people like blood as a measure for this, that and
    the other. For chronic intake of drugs, toxins, other things, in my opinion, hair is the way
    to go.” He testified that Employee’s Genova Screen revealed “significant [heavy metal]
    exposures . . . [a]nd that’s why I reasoned the causation between those exposures . . . .”
    Dr. Workman reported that the Genova Screen results showed Employee had 4.8 times
    the “accepted upper limit” of cadmium, 4.7 times the “accepted upper limit” of lead, and
    marginally elevated levels of antimony and gadolinium. Dr. Workman testified that his
    opinions and testimony were based on the Genova Screen and other doctors’ reports,
    acknowledging that the Genova Screen was “critical.”
    Dr. Workman further testified that he initially “equivocated” regarding the cause
    of Employee’s kidney disease and heart condition before reviewing research articles he
    obtained from the National Institute of Health’s website for his own “edification.” Dr.
    Workman discussed several studies he reviewed, including one he understood to link
    cadmium with processes of fatty liver, impaired gluconeogenesis, hypertension, and
    increased myocardial infarction risk. He explained that the study described how “fatty
    liver and liver necrosis typically cause[] hypertension,” stating that “we know that
    hypertension is a risk factor for myocardial infarction, congestive failure, et cetera.”
    Dr. Workman was asked to provide a causation opinion regarding the relationship
    between Employee’s work environment and the diseases involving his kidney, liver, and
    heart. When asked if heavy metal exposure primarily caused Employee’s diabetes, Dr.
    Workman opined, “I think that heavy metal exposure contributed to his diabetes . . . yes,
    it’s a primary cause among others. It’s not the primary cause but it’s a primary cause.”
    He similarly testified that antimony was the primary cause and lead exposure was “one of
    several primary causes” of Employee’s chronic renal failure. Dr. Workman testified that
    cadmium was “a contributing factor” to Employee’s heart attack, later clarifying that
    cadmium exposure was a “primary cause” of Employee’s heart attack and agreeing that it
    was more than fifty percent the cause of Employee’s heart attack. Dr. Workman also
    testified that exposure to lead and antimony were primary causes of Employee’s heart
    4
    disease, which he opined was a primary cause of his heart attack. However, when asked
    whether the metal exposure “primarily caused [Employee’s] cardiovascular disease,” Dr.
    Workman responded, “No. It’s a primary cause among others.”
    Dr. Workman could not recall if he reviewed any Material Safety Data Sheets
    (“MSDS”) for the metals used in Employer’s facility prior to giving his testimony. He
    had no reports of Employer’s air-sampling tests and did not review any TOSHA records.
    In the end, Dr. Workman testified that the “big battle of the experts has to do with hair.
    That’s what it boils down to.”
    Dr. Lee
    Dr. Lee is a physician, pharmacist, pharmacologist, and toxicologist licensed to
    practice medicine in Virginia. 3 He is not board certified and is not licensed to practice
    medicine in Tennessee. Dr. Lee performed a medical records review, examined
    Employer’s MSDS sheets, and reviewed Employee’s job description. However, he did
    not examine Employee, he did not order a heavy metal test, he did not visit Employer’s
    facility, and he did not perform any type of independent testing. Dr. Lee also did not
    review any reports of air testing or TOSHA records from Employer’s facility.
    Dr. Lee testified that, based on his review of the records and materials provided to
    him, Employee received a “sufficient dose” of heavy metal contaminants to cause his
    liver, kidney, and cardiovascular system to begin shutting down. He described a
    “cocktail effect” as occurring with exposure to multiple contaminants, which he testified
    can lead to a “synergistic effect” of all the toxins in Employee’s body. 4 Dr. Lee
    explained the synergistic effect as “one plus one equals four” and testified that “in this
    case, we have at least four heavy metals we know of that [Employee’s] been exposed to
    and at toxic levels . . . so this is like a one plus one plus one plus one. So it’s way beyond
    a one plus one equals four; it’s a one plus [one] – equals 20.”
    Dr. Lee testified that if an individual is exposed to heavy metals for long periods
    of time, the heavy metals will accumulate in the body and become more toxic. He
    identified four heavy metals detected by the Genova Screen at toxic levels: cadmium,
    lead, antimony, and arsenic. Dr. Lee testified that he was not “looking at any of these
    metals in isolation, but [was looking at] . . . the combination of them all,” since they all
    3
    Dr. Lee testified that he obtained a master’s degree in toxicology from Virginia Commonwealth
    University in 1999.
    4
    Dr. Lee testified that a “cocktail effect” is “when you have a mixture of components or chemicals that
    have an effect versus taking the individual entities, looking at them in isolation.” He explained further
    that “there are a variety of chemicals or substances . . . involved, so it’s a cocktail, which leads into a
    synergistic effect . . . so having the cocktail, whether they affect the same organ systems or different
    organ systems, you can’t look at any one in isolation but you have to look at them together.”
    5
    were “contributing factors [and] . . . they could have been a primary cause in and of
    themselves.” He testified that these heavy metals are deposited in the liver, kidneys, and
    spleen, noting there is an overlap of heavy metals affecting Employee’s organ system.
    He stated “[t]here is no doubt [Employee] was exposed to [heavy metals] . . . [t]here is no
    doubt that he had heavy metals in his body, some at toxic concentrations, and there is no
    doubt that he has [his] current health condition.”
    Like Dr. Workman, Dr. Lee also relied on the Genova Screen results to determine
    Employee’s levels of heavy metal contaminants. He testified that hair testing is the “gold
    standard” for evaluating long-term heavy metal exposure. He reviewed Employer’s
    MSDS sheets and confirmed that the materials Employer manufactured contained the
    heavy metals found in Employee’s system. Dr. Lee testified that he also considered
    Employee’s lengthy tenure working with heavy metals, years of work without barrier
    protection, and the kind of duties he performed for Employer in his analysis. He
    concluded that heavy metals were the primary cause of the damage to Employee’s liver,
    heart, and kidney, as well as the primary cause of Employee’s diabetes and pulmonary
    compromise.
    On cross-examination, Dr. Lee was questioned about his use of the Genova Screen
    as a diagnostic tool in light of the following language included on the report regarding
    diagnosis, treatment, and confirmation testing:
    NOTE: Commentary is provided to the practitioner for educational
    purposes, and should not be interpreted as diagnostic or treatment
    recommendations. Comments regarding clinical significance for the
    various elements are based on endogenous concentrations. Hair analysis is
    always a reflection of both endogenous levels and external contamination
    (elements on the hair surface), thus is considered a screen rather than a
    definitive diagnostic assessment of body burden.
    Dr. Lee testified the Genova Screen should be taken into consideration with the entire
    clinical picture and stated the screen “provides a key piece of information regarding
    [Employee’s] health history, work history, [and] exposure history.” He testified he did
    not use the Genova Screen for diagnostic purposes but considered the results of the
    Genova Screen in light of Employee’s lab tests, medical records, and documentation from
    other physicians who saw him. Dr. Lee confirmed the screen was a “key part of the
    whole clinical picture.” He disputed the need for confirmation testing and emphasized
    that the commentary in the report stated toxicity “may” be confirmed by blood or urine
    testing. In response to the issue of potential external contamination on the surface of the
    hair sample, Dr. Lee testified that the hair sample is washed “to eliminate or minimize the
    potential exogenous contamination.” He testified that the Genova Screen was “part of the
    clinical picture” in his analysis and an “important component” in forming his opinion.
    6
    Dr. Lee reviewed Employee’s oncology report from January 26, 2016, and agreed
    that the blood tests for lead, mercury, and arsenic were within normal limits. Dr. Lee also
    testified that he had not “seen or been provided with” any blood tests performed to check
    for cadmium, gadolinium, antimony, or beryllium. Dr. Lee stated that he did not know
    the levels of exposure Employee had to any metal contaminant at Employer’s facility,
    and, although he knew Employee’s job involved cutting metal, he was unaware of the
    location or conditions in Employer’s facility where this work was performed. He noted
    that evidence of toxic levels of heavy metals was derived from Employee’s hair samples,
    job description, clinical picture, and Employer’s MSDS sheets, but he did not have an air
    sample to corroborate the exposure levels. Dr. Lee acknowledged that he had not
    authored any publications on heavy metals and that this was his first time testifying in a
    case involving heavy metal exposure.
    Employer’s Expert Testimony
    Dr. Linfert
    Dr. Linfert is board certified in nephrology and internal medicine, specializing in
    kidneys and the treatment of renal failure. Dr. Linfert performed a records review and
    evaluated Employee on July 5, 2019. He documented a medical history of diabetes,
    hypertension, coronary disease, dyslipidemia, cirrhosis, renal disease, and stage three
    chronic kidney disease, along with other comorbidities. When asked how long Employee
    had renal disease, Dr. Linfert testified that Employee’s creatinine levels were elevated
    intermittently dating back to April 2014.
    Dr. Linfert noted the results of the Genova Screen revealed elevated levels of
    cadmium, lead, antimony, arsenic, and gadolinium, although the arsenic and gadolinium
    levels fell within the high normal range. Dr. Linfert testified that the maker of the
    Genova Screen emphasized the test was a screening tool and not to be used for diagnosis,
    stating that “if I were using this, I would – as the maker of the test says it’s not a
    diagnostic test, I would not use it as a diagnostic test.” He reiterated that “[p]er the
    company . . . it is not a diagnostic test” and testified that, based on his review of the
    Genova Screen, Genova Diagnostics would not consider the hair test to be an adequate
    way to assess causation. When asked what the Genova Screen recommended to
    determine accurate exposure levels, Dr. Linfert responded that the test result itself said
    that “confirmation of toxicity may be accomplished by a blood or urine testing.” Dr.
    Linfert also reviewed a lab report from Tennessee Oncology, dated January 26, 2016,
    which tested for arsenic, mercury, and lead, all of which were within normal ranges.
    When asked if he would rely on a hair test to determine the cause of renal failure, Dr.
    Linfert answered, “I would not.”
    Dr. Linfert testified that gadolinium, antimony, and beryllium are not associated
    with renal failure. He was not aware of any studies that suggested antimony was toxic to
    7
    kidneys in humans and testified that the National Institute of Health’s website made no
    comment on antimony’s renal toxicity in humans. Dr. Linfert noted that cadmium has the
    potential to be nephrotoxic but stated that it typically presents with significant changes in
    the urine prior to renal dysfunction. He said Employee did not have the classic
    presentation for this or for lead nephropathy. Dr. Linfert testified that diabetes,
    hypertension, and coronary artery disease were Employee’s most important medical
    concerns pertaining to renal failure. In addition, he noted that some of the medications
    Employee was taking could cause an elevation in creatinine levels, noting some had been
    linked to kidney disease. Dr. Linfert testified that Employee was overweight and had
    swelling in his legs. He stated that, “[c]onsidering all the possible etiologies of
    [Employee’s] renal disease, I believe his chronic kidney disease resulted from his
    underlying hypertension, diabetes and vascular disease.” Further, Dr. Linfert testified
    that “those are the three things that caused [Employee’s] chronic kidney disease
    definitively.”
    Dr. Linfert disagreed with Dr. Workman’s testimony that lead exposure was the
    primary cause of Employee’s renal failure. He testified that heavy metal exposures did
    not cause Employee’s obesity or contribute to his hypertension and did not affect his
    diabetes or vascular disease. Dr. Linfert said that he saw no need to order a heavy metal
    screen based on his review of Employee’s medical records, and that, with the exception
    of Dr. Workman’s report, he saw no reference to heavy metal exposure as a primary
    cause of Employee’s diseases in his review of Employee’s medical records.
    Dr. Schneider
    Dr. Schneider is a board-certified gastroenterologist and testified that this specialty
    encompasses the entire digestive system as well as the associated organs. He stated that
    one-third of his practice is focused on treating liver conditions. Dr. Schneider reviewed
    Employee’s medical records, including a 2013 liver biopsy, imaging studies, and the
    Genova Screen. He also performed a physical examination and documented Employee’s
    relevant medical history that included gastroesophageal reflux disease, high cholesterol,
    obesity, Type II Diabetes, high blood pressure, and heart disease.
    After reviewing Employee’s medical history, the report of the Genova Screen, and
    literature concerning heavy metal exposure, Dr. Schneider concluded he could not state
    whether the environmental exposures contributed to or caused Employee’s liver disease.
    Dr. Schneider testified that although the Genova Screen looked like a reasonable
    screening method, there was no confirmation testing to ascertain the accuracy of the
    screening results. In addition, Dr. Schneider testified that, according to Genova
    Diagnostics, its hair screening system was just that: a screen not intended to serve as a
    definitive diagnostic assessment of tissue levels. As a result, Dr. Schneider testified he
    would not consider the Genova Screen to be a valid diagnostic test. He testified that, in
    8
    his mind, a liver biopsy would be the only way to confirm whether Employee had toxic
    levels of heavy metals in his liver.
    Dr. Schneider also consulted LiverTox.nih.gov, a website sponsored by the
    National Institute of Health, and he testified that the information he read indicated
    cadmium “has not been linked specifically to clinically apparent liver injury in humans.”
    He noted that the website also indicated there “does not appear to be a major liver
    toxicity from environmental lead exposure.” He testified that arsenic was associated with
    non-cirrhotic portal hypertension in some individuals, but, unlike Employee, there was no
    cirrhosis in those individuals. He also testified that his review of the academic literature
    revealed no connection between antimony and liver disease or cirrhosis. Further, Dr.
    Schneider reviewed an article cited by Dr. Workman that linked low doses of cadmium to
    fatty liver disease in mice. He agreed that the study showed cadmium was toxic to the
    liver cells of mice but found no evidence relating cadmium exposure to human liver
    disease. He testified he “would not feel comfortable making any assumptions regarding
    humans based on animal studies.” In addition, Dr. Schneider found no evidence linking
    gadolinium exposure to liver disease.
    Dr. Schneider testified that he considered heavy metal exposure as a potential
    cause when evaluating Employee’s liver disease but that, in his opinion, the primary
    cause of Employee’s liver disease was a “combination of his diabetes, obesity, and high
    cholesterol, which induces the fatty liver, which causes inflammation and, over time,
    turns into scar tissue.” He noted that Employee has persistent liver disease, but no
    history of ascites, and he testified that the primary cause of Employee’s liver condition is
    the “synergistic effect between obesity, high cholesterol, diabetes, which incites
    inflammation of the liver, and, ultimately, fibrosis and cirrhosis.” 5 He testified that
    Employee’s diabetes, cholesterol, and obesity are not work-related conditions.
    Dr. Fleet
    Dr. Fleet is a cardiologist licensed to practice in Tennessee and is board certified
    in internal medicine, cardiology, and interventional cardiology. He was asked to perform
    a medical records review and provide an opinion regarding the cause of Employee’s heart
    disease and heart attack. In providing his opinions, Dr. Fleet noted Employee’s history of
    diabetes dating back to 2000, dyslipidemia with lipid abnormalities, high cholesterol,
    hypertension, severe obesity, untreated sleep apnea, anxiety, and a strong family history
    of coronary artery disease. Dr. Fleet testified there are five traditional significant risk
    factors for coronary artery disease: diabetes, hyperlipidemia, hypertension, family
    history, and smoking. He noted that Employee had four out of five of these factors and
    that he was at a “very high risk” of developing heart disease or having a heart attack.
    5
    Ascites is defined as “the abnormal accumulation of serous fluid in the spaces between tissues and
    organs in the cavity of the abdomen.” Merriam-Webster Dictionary (11th ed. 2016).
    9
    Dr. Fleet testified that the medical history taken by physicians at Memorial
    Hospital on the day Employee suffered his heart attack contained the same risk factors he
    described. He stated that Employee was also diagnosed with atrial fibrillation and noted
    that the risk factors for atrial fibrillation are similar to those for coronary disease: obesity,
    sleep apnea, diabetes, and coronary artery disease. He also agreed there was no record of
    work-related physical exertion or any mention of a sudden emotional stressor at work that
    could have triggered Employee’s heart attack. Dr. Fleet noted that Employee had pre-
    existing undiagnosed and untreated coronary artery disease when he had his heart attack.
    He testified Employee also had an angiogram that revealed severe coronary
    atherosclerotic disease and was diagnosed with systolic congestive heart failure. Dr.
    Fleet testified that Employee’s congestive heart failure was caused by coronary artery
    disease and that Employee’s left bundle branch block was caused by a combination of
    diabetes and coronary artery disease. Dr. Fleet further opined that “[t]he cause of
    [Employee’s] heart attack was severe coronary artery disease or coronary atherosclerosis.
    The cause of the coronary atherosclerosis was diabetes, dyslipidemia, obesity, family
    history, and secondary . . . a contribution of anxiety disorder and sleep apnea.” He
    testified that Employee’s chronic kidney disease had no causal relation to his heart
    disease. In addition, Dr. Fleet stated that, although Employee’s hypertension was well
    controlled, it may have been a minor contributing factor to his heart attack.
    Dr. Fleet opined that coronary artery disease is a complex process with multiple
    risk factors, all of which seem to be causative in some way. He testified that if he were
    making a list of causes of coronary artery disease, diabetes, obesity, dyslipidemia, and
    family history would be the primary causes. He stated that secondary risk factors would
    include untreated sleep apnea and anxiety disorder, and that “[h]eavy metal exposure
    comes in as an honorable mention.” Dr. Fleet testified that occupational exposure to
    heavy metals was not the primary cause of Employee’s heart attack or his need for
    treatment as a result of his heart attack. He did not believe heavy metal exposure was a
    significant contributing factor to Employee’s heart disease.
    Dr. Fleet further testified that lead and cadmium were not significant causes of
    cardiovascular disease, and that he was not aware of lead being known to increase
    cardiovascular mortality. Instead, he said that whether lead exposure plays any role
    would be “highly speculative at best” and testified there are “large epidemiologic studies
    that show a slight increased incidence of cardiovascular risk associated with cadmium.”
    He also agreed there is an epidemiologic[al] study showing arsenic has a slight
    association with increased cardiovascular risk but noted it was an “association, not []
    causation.” Dr. Fleet also testified that he was not aware of any link between heavy
    metal exposure and diabetes or high cholesterol. Based upon his expertise and his review
    of the medical records, he opined that, considering all causes, Employee’s coronary
    artery disease was not primarily related to any toxin exposure he may have had at work.
    10
    Compensation Hearing
    At trial, Employee and a representative of Employer were the only witnesses to
    testify in person. Employer’s representative testified that Employer is required to
    conduct air sampling whenever there are environmental changes due to equipment
    movement and that Employer requires air sampling every five years. He testified that air
    sampling is conducted by an independent company and that random employees are
    selected to wear air sampling kits for an eight-hour shift. Further, he testified that the
    sampling kits test for antimony, beryllium, cadmium, chromium, cobalt, copper, iron
    oxide, lead, manganese, molybdenum, nickel, vanadium, and zinc oxide.
    No evidence was offered at trial of any OSHA or TOSHA violations concerning
    air quality or excessive heavy metal exposure at Employer’s facility. Records for an
    August 10, 2018 OSHA inspection of Employer’s facility were introduced. Employer
    was cited for not determining the eight-hour time-weighted average exposure for each
    employee exposed to chromium and for the lack of signage identifying hazardous
    chemicals, both of which were corrected during the inspection. Employer was also cited
    for not including chromium in its hazard communication program and for not providing
    appropriate information or training for all employees exposed to chromium. During the
    2018 inspection, air sampling reflected that chromium exposure was below detectable
    limits. In 2019, an exposure monitoring survey was conducted with particulate exposure
    testing for antimony, beryllium, cadmium, chromium, cobalt, copper, iron oxide, lead,
    manganese, molybdenum, nickel, vanadium, and zinc oxide. Testing results revealed no
    operations that created exposure hazards above the permissible exposure limits. 6
    After the trial, the court issued an order concluding that “the causation opinions of
    Drs. Workman and Lee give the more probable explanation for the development of
    [Employee’s] liver, cardiac, and kidney conditions” and finding that Employee had
    proven by a preponderance of the evidence that his liver, cardiac, and kidney conditions
    arose primarily out of and in the course and scope of his employment. The trial court
    further concluded that Employee “sustained a single occupational disease from his
    exposure to heavy-metal contaminants . . . that manifested in his development of liver,
    cardiac, and kidney conditions.” The court ordered Employer to provide reasonable and
    necessary medical benefits for “treatment of [Employee’s] liver, cardiac, and kidney
    conditions,” as well as permanent partial disability benefits in the amount of $172,
    832.00, representing a fifty-nine percent disability. Employer has appealed.
    6
    Employer produced other ventilation studies and air-sampling results from 2002 and 2006 that revealed
    no heavy metal exposures beyond OSHA’s permissible exposure limits.
    11
    Standard of Review
    The standard we apply in reviewing a trial court’s decision presumes that the
    court’s factual findings are correct unless the preponderance of the evidence is otherwise.
    See Tenn. Code Ann. § 50-6-239(c)(7) (2019). When the trial judge has had the
    opportunity to observe a witness’s demeanor and to hear in-court testimony, we give
    considerable deference to factual findings made by the trial court. Madden v. Holland
    Grp. of Tenn., Inc., 
    277 S.W.3d 896
    , 898 (Tenn. 2009). However, “[n]o similar
    deference need be afforded the trial court’s findings based upon documentary evidence.”
    Goodman v. Schwarz Paper Co., No. W2016-02594-SC-R3-WC, 2018 Tenn. LEXIS 8, at
    *6 (Tenn. Workers’ Comp. Panel Jan. 18, 2018). Similarly, the interpretation and
    application of statutes and regulations are questions of law that are reviewed de novo with
    no presumption of correctness afforded the trial court’s conclusions. See Mansell v.
    Bridgestone Firestone N. Am. Tire, LLC, 
    417 S.W.3d 393
    , 399 (Tenn. 2013). We are
    also mindful of our obligation to construe the workers’ compensation statutes “fairly,
    impartially, and in accordance with basic principles of statutory construction” and in a
    way that does not favor either the employee or the employer. Tenn. Code Ann. § 50-6-
    116 (2019).
    Analysis
    Employer raises two issues on appeal, which we combine and restate as a single
    issue: whether the trial court erred in finding Employee’s medical experts established by
    a preponderance of the evidence that he suffered a compensable occupational disease
    arising primarily out of his employment, considering all causes. We conclude the trial
    court erred in assessing the relative weight to be afforded the parties’ experts and in
    finding Employee met his burden of proof in establishing he suffers from an occupational
    disease.
    As we have previously observed, an injured worker has the burden of proof on
    every essential element of his or her claim by a preponderance of the evidence. Tenn.
    Code Ann. § 50-6-239(c)(6); see also Buchanan v. Carlex Glass Co., No. 2015-01-0012,
    2015 TN Wrk. Comp. App. Bd. LEXIS 39, at *5 (Tenn. Workers’ Comp. App. Bd. Sept.
    29, 2015). Tennessee Code Annotated section 50-6-102(14) (2019) defines “injury” and
    “personal injury” to mean an “injury by accident, a mental injury, occupational disease
    including diseases of the heart, lung and hypertension, or cumulative trauma
    conditions . . . arising primarily out of and in the course and scope of employment, that
    causes . . . disablement or the need for medical treatment.” Moreover, an injury arises
    primarily out of and in the course and scope of employment “if it has been shown by a
    preponderance of the evidence that the employment contributed more than fifty percent
    (50%) in causing the injury, considering all causes.” Tenn. Code Ann. § 50-6-
    102(14)(B). “An injury causes death, disablement or the need for medical treatment only
    if it has been shown to a reasonable degree of medical certainty that it contributed more
    12
    than fifty percent (50%) in causing the death, disablement or need for medical treatment,
    considering all causes.” Tenn. Code Ann. § 50-6-102(14)(C). “‘Shown to a reasonable
    degree of medical certainty’ means that, in the opinion of the physician, it is more likely
    than not considering all causes, as opposed to speculation or possibility.” Tenn. Code
    Ann. § 50-6-102(14)(D).
    Moreover, a trial court “has the discretion to determine which testimony to accept
    when presented with conflicting expert opinions.” Payne v. UPS, No. M2013-02363-SC-
    R3-WC, 2014 Tenn. LEXIS 1112, at *18 (Tenn. Workers’ Comp. Panel Dec. 30, 2014).
    When such opinions conflict, a trial court may consider, among other things, “the
    qualifications of the experts, the circumstances of their examination, the information
    available to them, and the evaluation of the importance of that information by other
    experts.” Bass v. The Home Depot U.S.A., Inc., No. 2016-06-1038, 2017 TN Wrk.
    Comp. App. Bd. LEXIS 36, at *9 (Tenn. Workers’ Comp. App. Bd. May 26, 2017). We
    will review any such determination under an abuse of discretion standard. Sanker v.
    Nacarato Trucks, Inc., No. 2016-06-0101, 2016 TN Wrk. Comp. App. Bd. LEXIS 27, at
    *12 (Tenn. Workers’ Comp. App. Bd. July 6, 2016). A trial court abuses its discretion
    when it causes an injustice to the party challenging the decision by (1) applying an
    incorrect legal standard, (2) reaching an illogical or unreasonable decision, or (3) basing
    its decision on a clearly erroneous assessment of the evidence. See State v. Ostein, 
    293 S.W.3d 519
    , 526 (Tenn. 2009); Konvalinka v. Chattanooga-Hamilton Cnty. Hosp. Auth.,
    
    249 S.W.3d 348
    , 358 (Tenn. 2008); Doe 1 ex rel. Doe 1 v. Roman Catholic Diocese of
    Nashville, 
    154 S.W.3d 22
    , 42 (Tenn. 2005).
    In addition, we are charged with reviewing deposition testimony and documentary
    evidence de novo. See Brees v. Escape Day Spa & Salon, No. 2014-06-0072, 2015 TN
    Wrk. Comp. App. Bd. LEXIS 5, at *16 (Tenn. Workers’ Comp. App. Bd. Mar. 12, 2015)
    (“[T]he trial court occupies no better position than this Appeals Board in reviewing and
    interpreting documentary evidence.”). When the trial court’s determination is challenged
    on appeal, we must determine where the preponderance of the evidence lies. See Tenn.
    Code Ann. § 50-6-239(c)(7).
    In the present case, Employee contends he suffered occupational diseases of his
    heart, liver, and kidney as a result of his workplace exposure to heavy metals. The trial
    court relied on Employee’s experts’ testimony suggesting that Employee’s history of
    occupational exposure to heavy metals supported the reliability of the Genova Screen
    results, which measures the presence of heavy metals in a hair sample. Dr. Workman and
    Dr. Lee opined that hair test screens were more helpful than blood and urine testing in
    detecting the long-term presence of heavy metal contaminants because hair testing
    measures accumulated contaminant levels. However, despite the admonition on the test
    report indicating it was a screening tool and not a diagnostic tool, Dr. Workman and Dr.
    Lee relied heavily on the Genova Screen to provide causation opinions addressing
    Employee’s liver, kidney, and heart diseases. As explained below, we conclude the
    13
    preponderance of the evidence supports a finding that the Genova Screen was an
    insufficient basis to support a finding of medical causation based upon the entirety of the
    expert testimony presented at trial. In addition, we conclude the trial court erred in its
    consideration of the relative qualifications of the experts. Finally, we conclude that the
    trial court erred in assigning greater weight to the causation opinions of Drs. Workman
    and Lee. Accordingly, we find the trial court abused its discretion in accepting the
    opinions of Drs. Workman and Lee over those of Drs. Linfert, Schneider, and Fleet.
    The Genova Screen
    Dr. Workman and Dr. Lee relied on the results of the Genova Screen to provide
    causation opinions for Employee’s liver, kidney, and heart diseases. We previously set
    out the following guidance from Genova Diagnostics concerning the Genova Screen
    when addressing Dr. Lee’s testimony. We find the guidance significant and worthy of
    reiteration here:
    NOTE: Commentary is provided to the practitioner for educational
    purposes, and should not be interpreted as diagnostic or treatment
    recommendations. Comments regarding clinical significance for the
    various elements are based on endogenous concentrations. Hair Analysis is
    always a reflection of both endogenous levels and external contamination
    (elements on the hair surface), thus is considered a screen rather than a
    definitive diagnostic assessment of body burden.
    (Emphasis added.) Put simply, the test itself cautions against making any diagnostic or
    treatment recommendations based solely on the results. Moreover, the test recognizes
    that, due to potential contamination of the hair sample being tested, definitive diagnosis
    of exposure to heavy metals should be confirmed by additional methods. Although Dr.
    Lee stated that hair testing protocol includes washing the hair sample, the Genova Screen
    report is silent as to sample washing, and Dr. Lee provided no testimony regarding
    personal knowledge of Genova Diagnostics’ testing procedures.
    The Genova Screen also instructs:
    [t]he following comments regarding clinical significance for the elements
    tested in this profile are based on endogenous concentrations. It should be
    noted that Hair Analysis is a reflection of both endogenous levels and
    external contamination (elements on hair surface), thus this is considered a
    screen rather than a definitive diagnostic assessment of tissue levels.
    Confirmation of toxicity may be accomplished via blood or urine testing.
    (Emphasis added.) Again, the developers of the test emphasize that the Genova Screen is
    just that – a screen, and it does not provide a definitive assessment of the levels of heavy
    14
    metals found in tissue. Because of this, the test explicitly provides that confirmation of
    toxicity may be accomplished by blood or urine testing. In the present case, no
    confirmation testing was performed. As a result, the validity and reliability of the
    evidence used to establish the presence and extent of heavy metal contaminants
    accumulated in Employee’s system is suspect at best. In our view, Employee did not
    establish by a preponderance of the evidence that he was injuriously exposed to heavy
    metal contaminates or, if he was, that any such contaminates accumulated in toxic levels
    in his body sufficient to cause the medical conditions he identified as the bases of his
    claims. As a result, he failed to meet his burden of proving by a preponderance of the
    evidence that his liver, kidney, and cardiac diseases were primarily caused by his
    employment. Accordingly, we conclude the Genova Screen, in and of itself, was an
    insufficient basis upon which to determine medical causation.
    Weight of Expert Testimony
    In weighing the expert testimony, the trial court focused on the methodologies
    each expert used in forming their causation opinions. After reviewing the expert opinions
    and other evidence, the trial court determined that the causation opinions of Drs.
    Workman and Lee gave the more probable explanation for the development of
    Employee’s liver, cardiac, and kidney conditions. In reaching this conclusion, the trial
    court emphasized the length of time Employee worked at Employer’s facility without
    respiratory protective equipment and the “improbability of [Employee] developing non-
    alcoholic cirrhosis of the liver [and] respiratory issues without smoking, and cardiac and
    kidney conditions without the intervention of [Employee’s] exposure to heavy metals[.]”
    Based upon our review of the record, and taking into consideration the issues concerning
    the Genova Screen as discussed above, we conclude the trial court erred in determining
    that the opinions expressed by Drs. Workman and Lee outweighed the testimony of Drs.
    Linfert, Schneider, and Fleet with respect to causation of Employee’s kidney, liver, and
    heart diseases.
    Considering the qualifications of each expert, we note that Dr. Lee is a primary
    care physician with a master’s degree in pharmacology and toxicology. He is not board
    certified in toxicology and is not licensed to practice medicine in Tennessee. Dr. Lee
    testified to working as a pharmacist and medical examiner and to overseeing occupational
    drug screens for two facilities in his capacity as a Medical Review Officer. In addition,
    Dr. Lee has a medical practice where he sees adult patients with general medical issues,
    including issues related to environmental conditions. Although he has published no
    articles in the field of heavy metal exposure and could not recall ever testifying in a
    heavy metal exposure case, Dr. Lee testified he ordered heavy metal testing when
    necessary in his practice.
    Employee’s other expert, Dr. Workman, is a neuropsychiatrist who is board
    certified in psychiatry, neurology, and forensic medicine. He testified that he “pretty
    15
    much practiced neuropsychiatric pain medicine for the past 25 years.” He stated that he
    is basically a “clinical neuroscience doctor,” although he is board certified in the fields
    identified above. Dr. Workman testified that he is certified to do evaluations with the
    United States Department of Labor to determine the psychiatric impact of injuries. In
    addition, Dr. Workman noted that he is a master psychopharmacologist, which he said
    involved urine drug screens, measuring drug levels, and liver processes. In sum,
    although both Dr. Workman and Dr. Lee are practicing physicians qualified to offer
    expert testimony in their respective fields, neither is an expert in the areas of liver,
    kidney, or heart disease nor does their testimony indicate they have experience treating
    these complex conditions and determining their underlying causes on a regular basis.
    In contrast, Employer’s experts, Drs. Linfert, Schneider, and Fleet, are all board-
    certified practitioners licensed to practice medicine in Tennessee with many years of
    experience in their respective fields of liver, kidney, and heart disease. Each testified that
    part of their practice involves addressing multiple risk factors associated with complex
    health conditions and includes determining the underlying causes of those conditions.
    Dr. Linfert testified that sixty percent of his work is performed in the hospital setting,
    with remaining time split between his clinical practice, seeing patients in his office and a
    dialysis clinic, and heading the research group in his department. Dr. Linfert testified
    that he sees individuals with renal failure daily. Dr. Schneider is board certified in
    gastroenterology, a specialty that entails treatment of the gastrointestinal tract and its
    associated organs, which include the liver. As part of his practice, Dr. Schneider treats
    patients with liver disease and testified that one-third of his practice deals with liver
    related issues. Dr. Fleet is board certified in cardiology, interventional cardiology, and
    internal medicine. He has been a practicing cardiologist since 1994 and testified he treats
    heart disease in all its forms. In addition, Dr. Fleet has testified as a cardiovascular
    expert in medical malpractice claims.
    Based on the evidence presented at trial of the relative qualifications of all the
    testifying experts, we conclude the trial court erred in determining all experts were
    equally qualified to offer causation opinions as to kidney, liver, and heart diseases.
    Instead, we conclude the preponderance of the evidence favors the causation opinions of
    Dr. Linfert with respect to renal disease, the causation opinions of Dr. Schneider with
    respect to kidney disease, and the causation opinions of Dr. Fleet with respect to cardiac
    disease and Employee’s heart attack.
    The trial court also considered the manner in which each expert addressed
    causation in weighing the experts’ causation opinions. The trial court determined that Dr.
    Workman’s and Dr. Lee’s opinions were supported by the research and literature each
    specifically identified. The court also noted that, in formulating their opinions,
    Employee’s experts first “concluded that [Employee] had elevated levels of heavy-metal
    contaminants in his system and then researched the medical literature to determine if
    scientifically-documented links exist between liver, cardiac, and kidney conditions and
    16
    those metals.” Finally, the trial court noted that both testified as to the specific sources
    used in their causation analysis and supported their opinions with the literature they
    identified. However, Dr. Workman’s and Dr. Lee’s assessments of heavy metal
    contaminants were based in large part on results obtained from the Genova Screen. For
    the reasons previously expressed, the Genova Screen, standing alone, was not sufficient
    to establish medical causation. We conclude the preponderance of the evidence supports
    a finding that the opinions of Drs. Workman and Lee were less persuasive than those of
    Employer’s experts. In addition, the testimony of Employer’s experts casts doubt on the
    scientific studies upon which Drs. Workman and Lee relied, as well as on the accuracy of
    the conclusions drawn from those studies by Drs. Workman and Lee.
    The trial court stated that “[Employer’s] experts focused on [Employee’s]
    diagnoses of diabetes, coronary artery disease, hypertension, and family history of heart
    disease” in determining the primary cause of Employee’s conditions. The court
    characterized the heavy metal research of Employer’s experts as “vaguely-described
    literature research for links between heavy-metal exposure and liver, cardiac, and kidney
    conditions based on human testing.” The court concluded that Employer’s experts
    “minimalized the [Genova Screen] results and relied on the negative blood testing” in
    concluding that even if elevated heavy-metal exposure occurred, it would only result in a
    slight increase in contributing to the overall cause of Employee’s liver, kidney, and heart
    conditions. We respectfully disagree with the trial court’s reasoning on this issue.
    The record reveals that Dr. Linfert performed independent research regarding
    heavy metal exposure in relation to Employee’s kidney condition before concluding that
    Employee’s work exposure did not primarily cause his chronic kidney disease. Dr.
    Linfert testified about his research results and opined that, “[c]onsidering all the possible
    etiologies of [Employee’s] renal disease, I believe his chronic kidney disease resulted
    from his underlying hypertension, diabetes and vascular disease.” As a board-certified
    nephrologist, Dr. Linfert expressed concern with many of the articles Employee’s experts
    relied upon to support their opinions linking heavy metal exposure to Employee’s kidney
    condition, given that his own research did not reach the same conclusions. He also
    testified to conducting research regarding the potential impact of exposure to antimony,
    cadmium, and lead on the kidneys.
    With regard to Employee’s liver disease, Dr. Schneider also researched whether
    there is a documented causal link between heavy metal exposure and Employee’s
    condition, testifying that his research revealed no such causal link. Dr. Schneider
    testified in detail about specific research he conducted pertaining to the effect of heavy
    metal exposure on the liver. Dr. Schneider also read and disagreed with portions of Dr.
    Workman’s testimony, including characterizations and conclusions drawn from some of
    the studies Dr. Workman cited in relation to heavy metal exposure and its impact on the
    liver. Dr. Fleet testified that he considered heavy metal exposure as a potential cause of
    Employee’s cardiac condition but concluded that any such exposure would be deemed an
    17
    “honorable mention” in a hierarchy of risks, following secondary risk factors such as
    untreated sleep apnea and anxiety disorder.
    Drs. Linfert, Schneider, and Fleet all testified that preventative medicine is part of
    their practice, which they indicated includes trying to determine the cause of their
    patients’ underlying conditions. Employer’s experts unequivocally testified that
    Employee’s diseases were not primarily caused by workplace exposure to heavy metal
    contaminants. In addition, each expert testified that Employee’s comorbidities were not
    caused by Employee’s alleged exposures.
    In addition, we note that Dr. Workman’s causation testimony included phrases
    such as “a primary cause among others.” The Tennessee Workers’ Compensation Law
    defines the phrase “arises primarily out of and in the course and scope of employment” as
    requiring evidence that the employment “contributed more than fifty percent (50%) in
    causing the death, disablement or need for medical treatment, considering all causes.”
    Tenn. Code Ann. § 50-6-102(14)(B). Thus, in the context of an alleged occupational
    disease, the evidence must indicate that the occupational exposure was the primary cause
    of the disease, contributing more than 50% to the death, disablement or need for medical
    treatment, considering all causes. In short, it is mathematically impossible to have two or
    more “primary” causes, each contributing more than 50% to the cause of the death,
    disablement or need for medical treatment, as was suggested by Dr. Workman. As we
    have indicated before, a physician need not use “particular words or phrases included in
    the statutory definition of ‘injury’ to establish the requisite medical proof to succeed at
    trial . . . [and] a physician may render an opinion that meets the legal standard espoused
    in section 50-6-102(14) without couching the opinion in a rigid recitation of the statutory
    definition.” Panzarella v. Amazon, No. 2015-01-0383, 2017 TN Wrk. Comp. App. Bd.
    LEXIS 30, at *14 (Tenn. Workers’ Comp. App. Bd. May 15, 2017). However, “[w]hat is
    necessary,” we explained, “is sufficient proof from which the trial court can conclude that
    the statutory requirements of an injury as defined in section 50-6-102(14) are satisfied.”
    Id. (emphasis in original).
    Based on the foregoing, we conclude that the preponderance of the evidence does
    not support the trial court’s decision to accredit the causation opinions of Dr. Workman
    and Dr. Lee over those of Dr. Schneider, Dr. Fleet, and Dr. Linfert. Given their areas of
    expertise, their credentials, their experience, and their evaluation of the available
    information, we conclude the preponderance of the evidence establishes that Drs. Linfert,
    Schneider, and Fleet offered the more probable explanations of medical causation in their
    respective fields of expertise. Further, we conclude the trial court’s assessment of the
    expert evidence was clearly erroneous and constituted an abuse of discretion causing an
    injustice to Employer.
    Finally, we note Employee has challenged the constitutionality of Tennessee Code
    Annotated section 50-6-102(14) as applied to occupational diseases. We, like the trial
    18
    court, conclude we do not have the authority to address a facial challenge to the
    constitutionality of the statute. See, e.g., Richardson v. Board of Dentistry, 
    913 S.W.2d 446
    , 454 (Tenn.1995).
    Conclusion
    For the foregoing reasons, we conclude the trial court erroneously assessed the
    medical evidence, causing an injustice to Employer that constituted an abuse of the trial
    court’s discretion. Accordingly, we disagree with the trial court’s conclusion that
    Employee suffered a single occupational disease that arose primarily out of his
    employment, and we reverse the trial court’s order, dismiss Employee’s claim, and
    certify the reversed order as final for purposes of further appeal. Costs on appeal are
    taxed to Employee.
    19
    TENNESSEE BUREAU OF WORKERS’ COMPENSATION
    WORKERS’ COMPENSATION APPEALS BOARD
    Johnny Johnston                                       )      Docket Nos. 2015-01-0023, 2018-01-
    )                  0003 & 2018-01-0008
    v.                                                    )
    )      State File Nos. 9602-2015, 266-2018 &
    Siskin Steel & Supply Co./Reliance                    )                      1326-2018
    Steel & Aluminum Co., et al.                          )
    )
    )
    Appeal from the Court of Workers’                     )      Heard March 24, 2020, at Knoxville
    Compensation Claims                                   )
    Thomas L. Wyatt, Judge                                )
    CERTIFICATE OF SERVICE
    I hereby certify that a true and correct copy of the Appeals Board’s decision in the referenced
    case was sent to the following recipients by the following methods of service on this the 8th day
    of May, 2020.
    Name                              Certified   First Class   Via   Via     Sent to:
    Mail        Mail          Fax   Email
    Linn Guerrero-Justice                                               X     linn@loringjustice.com
    John Barringer                                                      X     jbarringer@manierherod.com
    Thomas L. Wyatt, Judge                                              X     Via Electronic Mail
    Kenneth M. Switzer, Chief Judge                                     X     Via Electronic Mail
    Penny Shrum, Clerk, Court of                                        X     penny.patterson-shrum@tn.gov
    Workers’ Compensation Claims
    Olivia Yearwood
    Clerk, Workers’ Compensation Appeals Board
    220 French Landing Dr., Ste. 1-B
    Nashville, TN 37243
    Telephone: 615-253-1606
    Electronic Mail: WCAppeals.Clerk@tn.gov
    

Document Info

Docket Number: 2018-01-0003

Judges: David F. Hensley, Timothy W. Conner, Pele I. Godkin

Filed Date: 5/8/2020

Precedential Status: Precedential

Modified Date: 1/9/2021